EPO Patents = 1

Forward Citations = 9

Loading Chart...

3 inventors (with patents filed for the assignee):

Ralph M Ellison (5 out of 5 patents)

Fred H Mermelstein (3 out of 9 patents)

Fred H Marmelstein (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 7205001 - Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds (2007-04-17),

2. 7179493 - Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds (2007-02-20),

3. 7163703 - Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds (2007-01-16),

4. 7132116 - Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds (2006-11-07),

5. 6875451 - Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds (2005-04-05),

Polarx Biopharmaceuticals, Inc. is a leading biotechnology company focused on developing innovative therapies for cancer treatment. With a dedicated team of scientists and researchers, Polarx is committed to advancing the field of biopharmaceuticals and improving patient outcomes. Their groundbreaking approach to drug development has the potential to revolutionize the way cancer is treated, offering new hope to patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#497 in Wilmington, DE

#694 in Delaware

#50,171 in US

Wilmington, DE, United States of America

Polarx Biopharmaceuticals, Inc.

Forward Citations = 9

3 inventors:

Ralph M Ellison (5 out of 5 patents)

Fred H Mermelstein (3 out of 9 patents)

Fred H Marmelstein (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com